• Wistar and Batavia Collaborate to Manufacture Rubella Vaccine contractpharma
    May 04, 2020
    ​The Wistar Institute and Batavia Biosciences have launched a strategic collaboration aimed to streamline the clinical grade manufacture and global distribution of Wistar’s rubella vaccine seed stock commonly known as RA 27/3.
PharmaSources Customer Service